Isaac KABA : From Kinshasa to California, the remarkable journey of a congolese scientist advancing medicine
mardi 7 juillet 2026
1K VuesFrom Kinshasa to the University of California, Isaac Kaba represents a new generation of African scientists pushing the boundaries of research. In this exclusive interview with Hi-Tech Afrique TV, he reflects on his journey, his work on the discovery of new cancer medicines, and his vision of an Africa fully committed to scientific innovation.
Hi-Tech Afrique TV : Could you introduce yourself to our audience and tell us about your journey from Kinshasa to the United States ?
Isaac KABA : My name is Isaac Kaba. I am currently a researcher at the University of California, Berkeley, and the Head of African Affairs at STEM for Development.
My journey began in Kinshasa, Democratic Republic of the Congo, where I observed that many people in my community relied on medicinal plants for healthcare. I became curious about the chemistry behind these natural remedies. That curiosity led me into research, first at the Faculty of Pharmaceutical Sciences at the University of Kinshasa, then at the University of Toledo in the United States. Today, I am pursuing doctoral research focused on the discovery of precision medicines in a prestigious scientific environment at the University of California, Berkeley, widely recognized as the world's leading public university.
From Kinshasa to California, it has always been the same spirit of curiosity that drives me to design and develop new medicines.
What inspired you to study pharmacy at the University of Kinshasa ?
Isaac K. : It really started with what I observed while growing up, particularly the widespread use of medicinal plants across almost every African community, as well as the major challenges people face in accessing quality healthcare in the Democratic Republic of the Congo.
As I mentioned earlier, I was deeply curious to understand the science and chemistry behind these traditional remedies. At the same time, I wanted to contribute to developing medicines that are more effective and less toxic by drawing inspiration from compounds that already exist in nature. That conviction led me to study pharmacy in Kinshasa.
How did your transition to the United States and the University of Toledo unfold ?
Isaac K. : The transition was far from easy. I had been told that applicants from Central Africa had less than a 10% chance of successfully transferring into an American university program. I had to translate all of my academic transcripts from French, understand a highly competitive and completely different admissions system, and, above all, remain persistent.
Eventually, I was admitted to the University of Toledo through a competitive scholarship, which became a major turning point in my development as a researcher.
What were the main challenges you faced as a Congolese researcher abroad ?
Isaac K. : The first challenge was establishing myself in a highly competitive research environment that was very different from what I had known. The research culture, working methods, and even the way scientific results are presented differ significantly from those in Kinshasa. I had to learn quickly in a new system where there were very few Congolese colleagues. Adapting to a different culture was also essential because scientific progress goes hand in hand with cultural integration.
Finally, the COVID-19 pandemic taught me a great deal about global health challenges. It forced all of us to rethink how research is conducted, how to collaborate remotely, and how to remain resilient in the face of uncertainty.
Your research has focused on prostate cancer. Why did you choose this particular disease ?
Isaac K. : Yes, indeed. That was one of the research projects I carried out during my time at the University of Toledo. Castration-resistant prostate cancer is an advanced and particularly difficult form of the disease to treat, affecting millions of men worldwide. It is also one of the most common cancers today. I wanted to tackle a major health challenge where there is still a significant need for new precision treatment approaches.
Could you explain, in simple terms, what your new treatment approach is based on ?
Isaac K. : Simply put, we sought to design new molecules that could become drug candidates capable of precisely targeting resistant cancer cells without affecting healthy cells. This approach aims to reduce the side effects commonly associated with cancer treatments. Our work led to the identification of three novel molecules, one of which showed particularly strong and promising activity, paving the way for further research to evaluate their potential as future medicines.
How could this research change the treatment of patients with prostate cancer ?
Isaac K. : Our long-term goal is to provide an alternative for patients whose current treatments are no longer effective, particularly those whose cancer has become highly resistant to conventional therapies. This is still fundamental research, but every new molecule we discover brings us one step closer to a future treatment.
What stage has your research project reached today ?
Isaac K. : This specific project on prostate cancer was conducted as part of my academic work at the University of Toledo. We are currently seeking a patent to protect the intellectual property before publishing our findings in a scientific journal.
At the University of California, Berkeley, my research has now evolved. I am currently working on the discovery of molecules capable of precisely modulating the immune system to treat both advanced cancers and autoimmune diseases such as diabetes, while building on the experience I gained from my previous research.
During the COVID-19 pandemic, you also worked on medicinal plants. What stands out to you from that experience ?
Isaac K. : It was a very meaningful experience ! Together with a research team at the University of Kinshasa, we investigated the biological properties of Congolese medicinal plants traditionally used to treat skin diseases, including certain types of skin cancer and exogenous ochronosis, commonly known as 'tampon' in Kinshasa.
We also conducted surveys among the Congolese population and traditional healers to document the medicinal plants used to treat respiratory illnesses during the COVID-19 pandemic. We created a database of these plants, and our findings were published.
What I remember most is that, even during a period of great uncertainty such as the COVID-19 pandemic, there was an opportunity to highlight and promote African traditional knowledge, which is too often overlooked.
In your opinion, what role can Africa play in global pharmaceutical research ?
Isaac K. : Africa has a crucial role to play, thanks both to its extraordinary biodiversity and the talent of its young scientists. The continent must become a key player in pharmaceutical innovation by collaborating with researchers around the world.
We should also encourage international exchange programs, because today, advances in biomedical and pharmaceutical sciences increasingly result from international collaborations and cross-border research networks rather than isolated efforts within a single country or institution. Such partnerships would also help promote African research on the global stage.
Do you believe that African medicinal plants still represent an underexplored source for the discovery of new medicines ?
Isaac K. : Absolutely ! We have an immense reservoir of traditional knowledge and biodiversity that remains largely underexplored from a scientific perspective. My own work on Congolese medicinal plants during the pandemic convinced me that there is tremendous potential, provided we invest in local research and build bridges between traditional knowledge and modern scientific methods.
You have received several prestigious awards, including the Pioneer Award (2023), the Sung-Hou and Rosalind Kim Graduate Fund in Chemical Biology (2024), and the GEM Fellowship (2025). What do these honors mean to you ?
Isaac K. : These awards are a recognition of the journey I have taken and of the value of pursuing work beyond conventional paths. They have encouraged me to continue moving forward and reminded me of the importance of following one's passion with perseverance. They have also strengthened my commitment to scientific research from the very beginning.
What are your next scientific and professional goals ?
Isaac K. : I am continuing my doctoral research at the University of California, Berkeley, where I am developing new tools to better understand and precisely modulate the immune system, with the hope of contributing to more effective treatments for cancer and autoimmune diseases.
In the long term, I aspire to continue advancing drug discovery as a professor and researcher, leading my own specialized research laboratory while remaining deeply committed to mentoring young African scientists.
Would you one day like to put your expertise at the service of the Democratic Republic of the Congo or collaborate with Congolese universities and research centers ?
Isaac K. : Yes, absolutely. It is an ambition that is very close to my heart. I remain deeply connected to the University of Kinshasa, where my academic journey began, and I hope to establish and facilitate lasting collaborations between Congolese institutions and international research centers so that scientific discoveries made in the DRC can benefit more people and gain greater international recognition.
What message would you like to share with young Africans who dream of a career in scientific research ?
Isaac K. : My message is simple : every challenge and every unexpected turn in your academic or research journey can become a hidden opportunity. Stay curious, persevere, and seek guidance from mentors and role models. Scientific research advances through collaboration and learning from others.
Keep exploring new ideas and always maintain an optimistic mindset. That is often how science works. Trust your instincts and follow your passion.
In your opinion, what needs to improve in Africa to enable more young researchers to emerge ?
Isaac K. : I believe we need to improve access to quality information and research resources across every scientific field. We must also invest much more in local research infrastructure so that young people are not held back from exploring new ideas and innovating in their respective disciplines.
Africa must also strengthen its system of mentoring young scientific talent. This is one of the reasons I am involved with STEM for Development, where I help identify outstanding talent across Francophone Africa and provide aspiring researchers with the resources they need to thrive in STEM fields.
Finally, what is your greatest dream as a scientist ?
Isaac K. : My greatest dream is to see my research contribute directly to treatments that improve patients' lives, especially in regions where access to quality healthcare remains a major challenge.
My greatest ambition is to know that the knowledge we produce will one day save lives. At the same time, I hope to see a new generation of young African researchers emerge scientists who will transform and innovate across the fields of STEM.
Interview conducted by Prisca Yandobia.
Editorial Office Contact :
Phone : +243 81 29 20 206
Email : contact@hi-techafriquetv.net